670 related articles for article (PubMed ID: 21329834)
1. Assessment of myocardial fibrosis with cardiovascular magnetic resonance.
Mewton N; Liu CY; Croisille P; Bluemke D; Lima JA
J Am Coll Cardiol; 2011 Feb; 57(8):891-903. PubMed ID: 21329834
[TBL] [Abstract][Full Text] [Related]
2. Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis--a clinical study using myocardial T1-mapping and extracellular volume quantification.
Ntusi NA; Piechnik SK; Francis JM; Ferreira VM; Rai AB; Matthews PM; Robson MD; Moon J; Wordsworth PB; Neubauer S; Karamitsos TD
J Cardiovasc Magn Reson; 2014 Mar; 16(1):21. PubMed ID: 24593856
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular magnetic resonance imaging to assess myocardial fibrosis in valvular heart disease.
Podlesnikar T; Delgado V; Bax JJ
Int J Cardiovasc Imaging; 2018 Jan; 34(1):97-112. PubMed ID: 28642994
[TBL] [Abstract][Full Text] [Related]
4. Histological Validation of measurement of diffuse interstitial myocardial fibrosis by myocardial extravascular volume fraction from Modified Look-Locker imaging (MOLLI) T1 mapping at 3 T.
de Meester de Ravenstein C; Bouzin C; Lazam S; Boulif J; Amzulescu M; Melchior J; Pasquet A; Vancraeynest D; Pouleur AC; Vanoverschelde JL; Gerber BL
J Cardiovasc Magn Reson; 2015 Jun; 17(1):48. PubMed ID: 26062931
[TBL] [Abstract][Full Text] [Related]
5. MR imaging assessment of myocardial edema with T2 mapping.
Montant P; Sigovan M; Revel D; Douek P
Diagn Interv Imaging; 2015 Sep; 96(9):885-90. PubMed ID: 25697831
[TBL] [Abstract][Full Text] [Related]
6. Association between diffuse myocardial fibrosis by cardiac magnetic resonance contrast-enhanced T₁ mapping and subclinical myocardial dysfunction in diabetic patients: a pilot study.
Ng AC; Auger D; Delgado V; van Elderen SG; Bertini M; Siebelink HM; van der Geest RJ; Bonetti C; van der Velde ET; de Roos A; Smit JW; Leung DY; Bax JJ; Lamb HJ
Circ Cardiovasc Imaging; 2012 Jan; 5(1):51-9. PubMed ID: 22135399
[TBL] [Abstract][Full Text] [Related]
7. Diffuse Myocardial Fibrosis and Inflammation in Rheumatoid Arthritis: Insights From CMR T1 Mapping.
Ntusi NAB; Piechnik SK; Francis JM; Ferreira VM; Matthews PM; Robson MD; Wordsworth PB; Neubauer S; Karamitsos TD
JACC Cardiovasc Imaging; 2015 May; 8(5):526-536. PubMed ID: 25890584
[TBL] [Abstract][Full Text] [Related]
8. Myocardial injury in patients with acute ischemic stroke detected by cardiovascular magnetic resonance imaging.
Blaszczyk E; Hellwig S; Saad H; Ganeshan R; Stengl H; Nolte CH; Fiebach JB; Endres M; Kuhnt J; Gröschel J; Schulz-Menger J; Scheitz JF
Eur J Radiol; 2023 Aug; 165():110908. PubMed ID: 37315403
[TBL] [Abstract][Full Text] [Related]
9. Diffuse myocardial fibrosis in the systemic right ventricle of patients late after Mustard or Senning surgery: an equilibrium contrast cardiovascular magnetic resonance study.
Plymen CM; Sado DM; Taylor AM; Bolger AP; Lambiase PD; Hughes M; Moon JC
Eur Heart J Cardiovasc Imaging; 2013 Oct; 14(10):963-8. PubMed ID: 23389732
[TBL] [Abstract][Full Text] [Related]
10. Correlation between right ventricular T
Jellis CL; Yingchoncharoen T; Gai N; Kusunose K; Popović ZB; Flamm S; Kwon D
Int J Cardiovasc Imaging; 2018 Jan; 34(1):55-65. PubMed ID: 28357724
[TBL] [Abstract][Full Text] [Related]
11. Histological validation of cardiac magnetic resonance analysis of regional and diffuse interstitial myocardial fibrosis.
Iles LM; Ellims AH; Llewellyn H; Hare JL; Kaye DM; McLean CA; Taylor AJ
Eur Heart J Cardiovasc Imaging; 2015 Jan; 16(1):14-22. PubMed ID: 25354866
[TBL] [Abstract][Full Text] [Related]
12. T1, T2 Mapping and Extracellular Volume Fraction (ECV): Application, Value and Further Perspectives in Myocardial Inflammation and Cardiomyopathies.
Roller FC; Harth S; Schneider C; Krombach GA
Rofo; 2015 Sep; 187(9):760-70. PubMed ID: 26098250
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular magnetic resonance of cardiomyopathy in limb girdle muscular dystrophy 2B and 2I.
Rosales XQ; Moser SJ; Tran T; McCarthy B; Dunn N; Habib P; Simonetti OP; Mendell JR; Raman SV
J Cardiovasc Magn Reson; 2011 Aug; 13(1):39. PubMed ID: 21816046
[TBL] [Abstract][Full Text] [Related]
14. T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy.
aus dem Siepen F; Buss SJ; Messroghli D; Andre F; Lossnitzer D; Seitz S; Keller M; Schnabel PA; Giannitsis E; Korosoglou G; Katus HA; Steen H
Eur Heart J Cardiovasc Imaging; 2015 Feb; 16(2):210-6. PubMed ID: 25246502
[TBL] [Abstract][Full Text] [Related]
15. The role of cardiovascular MRI in heart failure and the cardiomyopathies.
White JA; Patel MR
Cardiol Clin; 2007 Feb; 25(1):71-95, vi. PubMed ID: 17478241
[TBL] [Abstract][Full Text] [Related]
16. Myocardial fibrosis by late gadolinium enhancement cardiovascular magnetic resonance in myotonic muscular dystrophy type 1: highly prevalent but not associated with surface conduction abnormality.
Cardona A; Arnold WD; Kissel JT; Raman SV; Zareba KM
J Cardiovasc Magn Reson; 2019 May; 21(1):26. PubMed ID: 31046780
[TBL] [Abstract][Full Text] [Related]
17. Contrast-free detection of myocardial fibrosis in hypertrophic cardiomyopathy patients with diffusion-weighted cardiovascular magnetic resonance.
Nguyen C; Lu M; Fan Z; Bi X; Kellman P; Zhao S; Li D
J Cardiovasc Magn Reson; 2015 Dec; 17():107. PubMed ID: 26631061
[TBL] [Abstract][Full Text] [Related]
18. Myocardial deformation imaging by two-dimensional speckle-tracking echocardiography in comparison to late gadolinium enhancement cardiac magnetic resonance for analysis of myocardial fibrosis in severe aortic stenosis.
Hoffmann R; Altiok E; Friedman Z; Becker M; Frick M
Am J Cardiol; 2014 Oct; 114(7):1083-8. PubMed ID: 25212549
[TBL] [Abstract][Full Text] [Related]
19. Myocardial tissue characterization by contrast-enhanced cardiac magnetic resonance imaging in subjects with prediabetes, diabetes, and normal controls with preserved ejection fraction from the general population.
Storz C; Hetterich H; Lorbeer R; Heber SD; Schafnitzel A; Patscheider H; Auweter S; Zitzelsberger T; Rathmann W; Nikolaou K; Reiser M; Schlett CL; von Knobelsdorff-Brenkenhoff F; Peters A; Schulz-Menger J; Bamberg F
Eur Heart J Cardiovasc Imaging; 2018 Jun; 19(6):701-708. PubMed ID: 28950340
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of late gadolinium enhancement CMR in nonischemic cardiomyopathies.
Karamitsos TD; Neubauer S
Curr Cardiol Rep; 2013 Jan; 15(1):326. PubMed ID: 23250662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
